{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T06:49:08Z","timestamp":1654325348766},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf00315306","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T14:10:00Z","timestamp":1097590200000},"page":"507-512","source":"Crossref","is-referenced-by-count":3,"title":["The consequences of H2 receptor antagonist ? piroxicam coadministration in patients with joint disorders"],"prefix":"10.1007","volume":"45","author":[{"given":"P. A.","family":"Milligan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"McGill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"37","volume":"3","author":"G Anod","year":"1983","unstructured":"Anod G, Jellheden B, Sodergren J (1983) Toleration of piroxicam. Int Med 3: 37?41","journal-title":"Int Med"},{"key":"CR2","first-page":"202","volume":"31","author":"WR Bartle","year":"1982","unstructured":"Bartle WR, Walker E, Shapero T (1982) Effect of cimetidine on phenytoin metabolism. Clin Pharmacol Ther 31: 202","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","first-page":"18","volume":"8","author":"K Brune","year":"1985","unstructured":"Brune K (1985) Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics. Eur J Rheumatol 8: 18?23","journal-title":"Eur J Rheumatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.1983.tb02096.x","volume":"15","author":"EJ Begg","year":"1983","unstructured":"Begg EJ, Williams KM, Wade DN, O'Shea KF (1983) No significant effect of cimetidine on the pharmacokinetics of misonidazole in man (letter). Br J Clin Pharmacol 15: 575?576","journal-title":"Br J Clin Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gut.26.4.359","volume":"26","author":"DStJ Collier","year":"1985","unstructured":"Collier DStJ, Pain JA (1985) Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 26: 359?363","journal-title":"Gut"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2125.1984.tb02516.x","volume":"18","author":"KA Conrad","year":"1984","unstructured":"Conrad KA, Mayersohn M, Bliss M (1984) Cimetidine does not alter ibuprofen kinetics after a single dose. Br J Clin Pharmacol 18: 624?626","journal-title":"Br J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00543328","volume":"28","author":"A Darragh","year":"1985","unstructured":"Darragh A, Gordon AJ, O'Byrne H, Hobbs D, Casey E (1985) Single and steady-state pharmakokinetics of piroxicam in elderly vs young adults. Eur J Clin Pharmacol 28: 305?309","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2125.1983.tb02192.x","volume":"16","author":"NG Dey","year":"1983","unstructured":"Dey NG, Castlden CM, Ward J, Cornhill J, McBurney A (1983) The effect of cimetidine on tolbutamide kinetics. Br J Clin Pharmacol 16: 438?440","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0049-0172(82)90072-5","volume":"12","author":"DJ Farnham","year":"1982","unstructured":"Farnham DJ (1982) Studies of isoxiam in combination with aspirin, warfarin sodium and cimetidine. Semin Arthritis Rheum 12 [Suppl 2]: 179?183","journal-title":"Semin Arthritis Rheum"},{"key":"CR10","first-page":"335","volume":"26","author":"JJ Grygiel","year":"1984","unstructured":"Grygiel JJ, Miners JO, Drew R, Birkett DJ (1984) Differential effects of cimetidine on theophylline metabolic pathways. Eur J Pharmacol 26: 335?340","journal-title":"Eur J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(79)91701-X","volume":"II","author":"D Hetzel","year":"1979","unstructured":"Hetzel D, Birkett D, Miners J (1979) Cimetidine interaction with warfarin. Lancet II: 639","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/j.1552-4604.1979.tb02480.x","volume":"19","author":"DC Hobbs","year":"1979","unstructured":"Hobbs DC, Twomey TM (1979) Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol 19: 270?281","journal-title":"J Clin Pharmacol"},{"key":"CR13","first-page":"91","volume-title":"The rheumatological disease process: focus on piroxicam","author":"DC Hobbs","year":"1984","unstructured":"Hobbs DC, Gordon AJ (1984) Absence of an effect of age on the pharmacokinetics of piroxicam. In: Richardson R. G. (ed) The rheumatological disease process: focus on piroxicam. The Royal Society Of Medicine, London pp 91?94"},{"key":"CR14","first-page":"251","volume":"29","author":"NHG Holford","year":"1981","unstructured":"Holford NHG, Altman D, Riegelman S, Buskin JN, Upton RA (1981) Pharmacokinetic and pharmacodynamic study of cimetidine administered with naproxen (abstract). Clin Pharmacol Ther 29: 251?252","journal-title":"Clin Pharmacol Ther"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01062535","volume":"7","author":"T Ishizaki","year":"1979","unstructured":"Ishizaki T, Nomura T, Abe T (1979) Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm 7: 369?381","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/clpt.1985.109","volume":"37","author":"A Klein","year":"1985","unstructured":"Klein A, Sami M, Selinger K (1985) Mexiletine kinetics in healthy subjects taking cimetidine. Clin Pharmacol Ther 37: 669?673","journal-title":"Clin Pharmacol Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0163-7258(87)90045-3","volume":"33","author":"U Klotz","year":"1987","unstructured":"Klotz U, Arvela P, Pasanen M, Kroemer H, Pelkonen O (1987) Comparative effects of H2-receptor antagonists on drug metabolism in vitro and in vivo. Pharmacol Ther 33: 157?161","journal-title":"Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0016-5085(82)90127-5","volume":"82","author":"RG Knodell","year":"1982","unstructured":"Knodell RG, Holtzman JL, Crankshaw DL, Steele NM, Stanley LA (1982) Drug metabolism by rat and human hepatic microsomes in response to interaction with H2 receptor antagonists. Gastroenterology 82: 84?88","journal-title":"Gastroenterology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/0016-5085(91)90408-D","volume":"101","author":"RG Knodell","year":"1991","unstructured":"Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680?1691","journal-title":"Gastroenterology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0016-5085(89)80060-5","volume":"96","author":"MJS Langman","year":"1989","unstructured":"Langman MJS (1989) Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 96: 640?646","journal-title":"Gastroenterology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(93)90285-B","volume":"52","author":"T Leemann","year":"1992","unstructured":"Leemann T, Transon C, Dayer P (1992) Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4?-hydroxylation in human liver. Life Sci 52: 29?34","journal-title":"Life Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/03602537908997468","volume":"10","author":"AYH Lu","year":"1979","unstructured":"Lu AYH (1979) Multiplicity of liver drug metabolism enzymes. Drug Metab Rev 10: 187?208","journal-title":"Drug Metab Rev"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-4347(92)80182-P","volume":"576","author":"PA Milligan","year":"1992","unstructured":"Milligan PA (1992) Determination of piroxicam and its major metabolites in the plasma, urine and bile of humans by HPLC. J Chromatogr Biomed Appl 576: 121?128","journal-title":"J Chromatogr Biomed Appl"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0016-5085(80)90450-3","volume":"79","author":"RV Patwardhan","year":"1980","unstructured":"Patwardhan RV, Yarborough GW, Desmond PV, Johnson RF, Schenker S, Speeg Jr KV (1980) Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology 79: 912?916","journal-title":"Gastroenterology"},{"key":"CR25","first-page":"77","volume":"72","author":"NE Pitts","year":"1982","unstructured":"Pitts NE (1982) Efficacy and safety of piroxicam. Am J Med 72: 77?87","journal-title":"Am J Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0006-2952(83)90584-1","volume":"32","author":"PEB Reilly","year":"1983","unstructured":"Reilly PEB, Carrington LE, Windsor DJ (1983) The interaction of cimetidine with rat liver microsomes. Biochem Pharmacol 32: 831?835","journal-title":"Biochem Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0016-5085(81)90647-8","volume":"81","author":"RK Roberts","year":"1981","unstructured":"Roberts RK, Grice J, Wood L, Petroff V, McGuffie C (1981) Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19","journal-title":"Gastroenterology"},{"key":"CR28","first-page":"303","volume":"4","author":"HJ Rogers","year":"1981","unstructured":"Rogers HJ, Spector RG, Morrison PJ, Bradbrook ID (1981) Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects. Eur J Rheumatol 4: 303?308","journal-title":"Eur J Rheumatol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02054259","volume":"5","author":"HE Rugstad","year":"1986","unstructured":"Rugstad HE, Hundal O, Holme I, Herland OB, Husby G, Giercksky K-E (1986) Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: relation to age, sex, efficacy and adverse events. Clin Rheumatol 5: 389?398","journal-title":"Clin Rheumatol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003088-198712050-00002","volume":"12","author":"A Somogyi","year":"1987","unstructured":"Somogyi A, Muirhead M (1987) Pharmacokinetic interactions of cimetidine 1987. Clin Pharmacokinet 12: 321?366","journal-title":"Clin Pharmacokinet"},{"key":"CR31","first-page":"789","volume":"13","author":"RK Verbeeck","year":"1986","unstructured":"Verbeeck RK, Richardson CJ, Blocka KLN (1986) Clinical pharmacokinetics of piroxicam. J Rheumatol 13: 789?796","journal-title":"J Rheumatol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2125.1983.tb02191.x","volume":"16","author":"AD Woolf","year":"1983","unstructured":"Woolf AD, Rogers HJ, Bradbrook ID, Corless D (1983) Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients. Br J Clin Pharmacol 16: 433?437","journal-title":"Br J Clin Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0024-3205(92)90226-F","volume":"51","author":"J Zhao","year":"1992","unstructured":"Zhao J, Leemann T, Dayer P (1992) In vitro oxidation of oxicam NSAIDS by a human liver cytochrome P450. Life Sci 51: 575?581","journal-title":"Life Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00315306\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T09:56:22Z","timestamp":1585907782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00315306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF00315306"],"URL":"https:\/\/doi.org\/10.1007\/bf00315306","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}